Shiho Ohno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shiho Ohno has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Yoshiki Yamaguchi
Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
13 shared publications - Noriyoshi Manabe
Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
7 shared publications - Jun Uzawa
Structural Glycobiology Team, RIKEN (The Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako 351-0198, Saitama, Japan
2 shared publications - Makoto Tsuiji
Department of Microbiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences
2 shared publications - Tadashi Kaname
Department of Genome Medicine National Center for Child Health and Development Tokyo Japan
2 shared publications Akito Ohuchi
Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University , 4-4-1 Komatsushima, Aoba-ku, Sendai, Miyagi 981-8558
1 shared publication
Latest Publications
- 7 November 2026
- Published by Oxford University Press (OUP) in Glycobiology
Structure-Based and Glycosylation-Aware Interpretation of Glycogene Variants
Missense variants in glycan-related genes (glycogenes) underlie many congenital disorders of glycosylation and related conditions, yet a large fraction remain classified as variants of uncertain significance. Because glycogenes often show low evolutionary conservation, conventional sequence-based predictors are frequently uninformative, making structure-based interpretation particularly valuable. This review examines how structure-based and glycosylation-aware approaches can improve the interpretation of glycogene variants. Advances in protein structure prediction, notably AlphaFold, now allow variant-induced structural perturbations to be assessed proteome-wide using structure-derived features such as solvent accessibility, thermodynamic stability (ΔΔG), and local model confidence (pLDDT). Such structural features can be combined to predict the impact of glycogene variants, as exemplified by VarMeter and VarMeter2, which have successfully identified pathogenic missense variants of arylsulfatase L (ARSL) and N-sulfoglucosamine sulfohydrolase (SGSH) in patients with undiagnosed disease. Despite the progress in these tools, there remain challenges especially relevant to glycobiology, including the limited accuracy of current ΔΔG predictors, the distinct behavior of gain-of-function and stabilizing variants, the need for proteome-scale computation, and the critical but still underexplored contribution of protein glycosylation to structural stability. We argue that incorporating glycosylation into structural energetics is a key next step toward more accurate, glyco-aware variant interpretation.
- 7 November 2026
- Published by Oxford University Press (OUP) in Glycobiology
Structure-Based and Glycosylation-Aware Interpretation of Glycogene Variants
Missense variants in glycan-related genes (glycogenes) underlie many congenital disorders of glycosylation and related conditions, yet a large fraction remain classified as variants of uncertain significance. Because glycogenes often show low evolutionary conservation, conventional sequence-based predictors are frequently uninformative, making structure-based interpretation particularly valuable. This review examines how structure-based and glycosylation-aware approaches can improve the interpretation of glycogene variants. Advances in protein structure prediction, notably AlphaFold, now allow variant-induced structural perturbations to be assessed proteome-wide using structure-derived features such as solvent accessibility, thermodynamic stability (ΔΔG), and local model confidence (pLDDT). Such structural features can be combined to predict the impact of glycogene variants, as exemplified by VarMeter and VarMeter2, which have successfully identified pathogenic missense variants of arylsulfatase L (ARSL) and N-sulfoglucosamine sulfohydrolase (SGSH) in patients with undiagnosed disease. Despite the progress in these tools, there remain challenges especially relevant to glycobiology, including the limited accuracy of current ΔΔG predictors, the distinct behavior of gain-of-function and stabilizing variants, the need for proteome-scale computation, and the critical but still underexplored contribution of protein glycosylation to structural stability. We argue that incorporating glycosylation into structural energetics is a key next step toward more accurate, glyco-aware variant interpretation.
- Open Access
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16  (41) , 48015-48019
Temperature-controlled conformational switching of squaramides enabled by side-chain hydrogen bonding
Precise control of local conformational bias is essential for constructing stimulus-responsive aromatic architectures.
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16  (41) , 48015-48019
Open AccessTemperature-controlled conformational switching of squaramides enabled by side-chain hydrogen bonding
Precise control of local conformational bias is essential for constructing stimulus-responsive aromatic architectures.
- Open Access
- 28 July 2026
- Published by Elsevier in Trends in Biotechnology
A rapid and high-throughput biotechnology quantifies major glycoforms of human IgG1 mAb drugs
- 28 July 2026
- Published by Elsevier in Trends in Biotechnology
Open AccessA rapid and high-throughput biotechnology quantifies major glycoforms of human IgG1 mAb drugs
- Open Access
- 17 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27  (12) , 5489
Prediction of Novel Disease-Related Regions in SIGLEC-7 by In Silico and Biochemical Analyses
SIGLECs are well-known receptors that distinguish self from non-self by binding to sialic acid-containing glycoconjugates, thereby regulating normal immune functions. They have also been associated with several diseases, including systemic sclerosis, leukemia, and Alzheimer’s disease. To identify pathogenic regions related to ligand binding in SIGLECs using a novel approach, we employed the in silico Individual Meta Random Forest (InMeRF) program, which predicts disease-related amino acid substitutions. InMeRF predicted a novel three-amino-acid motif (LSI) consisting of highly pathogenic amino acid residues in SIGLEC-7 and other CD33-related SIGLECs. Alanine substitution experiments and point-mutation energy calculations using SIGLEC-7 as a representative model member of the SIGLEC family showed that mutations in the LSI motif altered binding to ganglioside ligands compared with the wild type (WT) and affected structural stability, as reflected by changes in mutation energy. Structural analysis based on the crystal structure of SIGLEC-7 revealed that the LSI motif forms a buried β-strand located beneath the previously identified sialic acid-binding region (Site 2) in CD33-related SIGLEC-7. Taken together, these findings demonstrate the utility of InMeRF for identifying previously unrecognized pathogenic regions and provide new structural and functional insights into the SIGLEC family.
- 17 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27  (12) , 5489
Open AccessPrediction of Novel Disease-Related Regions in SIGLEC-7 by In Silico and Biochemical Analyses
SIGLECs are well-known receptors that distinguish self from non-self by binding to sialic acid-containing glycoconjugates, thereby regulating normal immune functions. They have also been associated with several diseases, including systemic sclerosis, leukemia, and Alzheimer’s disease. To identify pathogenic regions related to ligand binding in SIGLECs using a novel approach, we employed the in silico Individual Meta Random Forest (InMeRF) program, which predicts disease-related amino acid substitutions. InMeRF predicted a novel three-amino-acid motif (LSI) consisting of highly pathogenic amino acid residues in SIGLEC-7 and other CD33-related SIGLECs. Alanine substitution experiments and point-mutation energy calculations using SIGLEC-7 as a representative model member of the SIGLEC family showed that mutations in the LSI motif altered binding to ganglioside ligands compared with the wild type (WT) and affected structural stability, as reflected by changes in mutation energy. Structural analysis based on the crystal structure of SIGLEC-7 revealed that the LSI motif forms a buried β-strand located beneath the previously identified sialic acid-binding region (Site 2) in CD33-related SIGLEC-7. Taken together, these findings demonstrate the utility of InMeRF for identifying previously unrecognized pathogenic regions and provide new structural and functional insights into the SIGLEC family.
- 1 May 2026
- Published by Springer Nature
- p. 695-697
VarMeter: A Tool for Assessing the Structural Consequences of Genetic Variants
- 1 May 2026
- Published by Springer Nature
- p. 695-697
VarMeter: A Tool for Assessing the Structural Consequences of Genetic Variants
- 1 May 2026
- Published by Springer Nature
- p. 699-702
Computational Chemistry and Artificial Intelligence: Advances Through Supercomputing
- 1 May 2026
- Published by Springer Nature
- p. 699-702
Computational Chemistry and Artificial Intelligence: Advances Through Supercomputing
- 3 March 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36  (4)
Integrative structural analysis of lacto- N -fucopentaose I recognition by antibodies R-17F and R-13E using NMR, docking, and molecular dynamics simulations
Anti-glycan antibodies have become essential tools in biochemical assays, tissue staining, and diagnostic applications; however, the structural basis of glycan–antibody interactions is poorly understood, limiting rational design of antibodies with enhanced affinity and specificity. Key challenges include the crystallization of glycan–antibody complexes and the acquisition of complete electron density maps of bound glycans. To gain insight into the mechanisms of interaction between antibodies and glycans, here we constructed three-dimensional models of glycan–antibody complexes by integrating NMR spectroscopy with computational simulations. As a representative system, we selected lacto-N-fucopentaose I (LNFP I), which is expressed on undifferentiated induced pluripotent stem cells, and two anti-glycan monoclonal antibodies, R-17F and R-13E. Saturation transfer difference NMR of antibody–glycan solutions indicated that the fucose and N-acetylglucosamine moieties of LNFP I lie in close spatial proximity to the antibody and likely form the interaction surface, with R-17F exhibiting broader contact and more stable binding than R-13E. These data were used as experimental constraints for constructing antibody–glycan complex models through molecular docking and molecular dynamics simulations based on an LNFP I crystal structure and AlphaFold models of the antibody Fv fragment. The resulting models revealed that the non-reducing end of LNFP I is specifically recognized by both R-17F and R-13E, while the reducing end is exposed to the solvent, suggesting compatibility with its native glycolipid anchor. This study provides new structural insights into glycan–antibody recognition and highlights the utility of combining NMR and molecular simulations for the rational design of glycan-targeting antibodies.
- 3 March 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36  (4)
Integrative structural analysis of lacto- N -fucopentaose I recognition by antibodies R-17F and R-13E using NMR, docking, and molecular dynamics simulations
Anti-glycan antibodies have become essential tools in biochemical assays, tissue staining, and diagnostic applications; however, the structural basis of glycan–antibody interactions is poorly understood, limiting rational design of antibodies with enhanced affinity and specificity. Key challenges include the crystallization of glycan–antibody complexes and the acquisition of complete electron density maps of bound glycans. To gain insight into the mechanisms of interaction between antibodies and glycans, here we constructed three-dimensional models of glycan–antibody complexes by integrating NMR spectroscopy with computational simulations. As a representative system, we selected lacto-N-fucopentaose I (LNFP I), which is expressed on undifferentiated induced pluripotent stem cells, and two anti-glycan monoclonal antibodies, R-17F and R-13E. Saturation transfer difference NMR of antibody–glycan solutions indicated that the fucose and N-acetylglucosamine moieties of LNFP I lie in close spatial proximity to the antibody and likely form the interaction surface, with R-17F exhibiting broader contact and more stable binding than R-13E. These data were used as experimental constraints for constructing antibody–glycan complex models through molecular docking and molecular dynamics simulations based on an LNFP I crystal structure and AlphaFold models of the antibody Fv fragment. The resulting models revealed that the non-reducing end of LNFP I is specifically recognized by both R-17F and R-13E, while the reducing end is exposed to the solvent, suggesting compatibility with its native glycolipid anchor. This study provides new structural insights into glycan–antibody recognition and highlights the utility of combining NMR and molecular simulations for the rational design of glycan-targeting antibodies.
- 24 February 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36  (4)
Structural determinants of site-specific Core Fucosylation in human transferrin: insights from crystallography and molecular dynamics
Core fucosylation of N-glycans, catalyzed by fucosyltransferase 8 (FUT8), plays a crucial role in various biological processes; however, the structural factors that determine which glycans are site-specifically modified by FUT8 remain poorly understood. Human transferrin carries two N-glycans at Asn432 and Asn630, of which only that at Asn630 is core-fucosylated in serum and cerebrospinal fluids. Here we compared the structural features of the two glycosylation sites on human transferrin as a model protein using crystallographic data and molecular dynamics (MD) simulations. Based on 13 crystal structures of transferrin with sufficient resolution, the solvent accessibility of the two glycosylation sites, Asn432 and Asn630, is 94 ± 17 Å2 and 120 ± 23 Å2, respectively, suggesting that Asn630 exhibits higher solvent accessibility. MD simulations of a glycosylated transferrin model based on AlphaFold predictions revealed that GlcNAc-1, the specific target of FUT8, is consistently more solvent-exposed at Asn630 than at Asn432, while root mean square fluctuation values showed that the glycan at Asn630 exhibits greater flexibility across all sugar residues. Hydrogen bond analysis further indicated that the glycan at Asn432 forms multiple stable interactions with the protein surface, whereas the Asn630 glycan shows minimal contact. These findings suggest that increased solvent accessibility, enhanced flexibility, and reduced structural constraints at Asn630 facilitate access by FUT8, enabling site-specific core fucosylation of transferrin.
- 24 February 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36  (4)
Structural determinants of site-specific Core Fucosylation in human transferrin: insights from crystallography and molecular dynamics
Core fucosylation of N-glycans, catalyzed by fucosyltransferase 8 (FUT8), plays a crucial role in various biological processes; however, the structural factors that determine which glycans are site-specifically modified by FUT8 remain poorly understood. Human transferrin carries two N-glycans at Asn432 and Asn630, of which only that at Asn630 is core-fucosylated in serum and cerebrospinal fluids. Here we compared the structural features of the two glycosylation sites on human transferrin as a model protein using crystallographic data and molecular dynamics (MD) simulations. Based on 13 crystal structures of transferrin with sufficient resolution, the solvent accessibility of the two glycosylation sites, Asn432 and Asn630, is 94 ± 17 Å2 and 120 ± 23 Å2, respectively, suggesting that Asn630 exhibits higher solvent accessibility. MD simulations of a glycosylated transferrin model based on AlphaFold predictions revealed that GlcNAc-1, the specific target of FUT8, is consistently more solvent-exposed at Asn630 than at Asn432, while root mean square fluctuation values showed that the glycan at Asn630 exhibits greater flexibility across all sugar residues. Hydrogen bond analysis further indicated that the glycan at Asn432 forms multiple stable interactions with the protein surface, whereas the Asn630 glycan shows minimal contact. These findings suggest that increased solvent accessibility, enhanced flexibility, and reduced structural constraints at Asn630 facilitate access by FUT8, enabling site-specific core fucosylation of transferrin.
- Open Access
- 8 July 2025
- Published by Springer Nature in Journal of Human Genetics
VarMeter: a prediction method for the impact of glycogene variants
The clinical relevance of glycans, which play a wide array of physiological roles, is underscored by the emergence of congenital disorders of glycosylation, a group of rare inherited diseases caused by defects in glycan-related genes (glycogenes). Biochemical studies of recombinant proteins and phenotypic analyses in knockout mice are revealing critical insights into the roles of various glycosyltransferases, glycosidases, and glycan-binding proteins. However, the biological functions of numerous glycogenes and their role in disease remain incompletely understood, partly due to human-specific functions that are not recapitulated in model organisms, and partly due to the structural diversity and complexity of glycan modifications, which are difficult to fully assess by conventional methods. A promising complementary strategy is the systematic assessment of human genetic variants, particularly missense mutations, to infer functional consequences. Recent developments in protein structure prediction, exemplified by AlphaFold, are facilitating the development of structure-based approaches to variant interpretation. In this review, we discuss current methodologies for predicting the impact of missense variants using structural information, and introduce VarMeter, a computational framework incorporating 3D structural parameters that has been successfully applied to the prediction of pathogenic variants in the ClinVar database. We also describe VarMeter2, an updated version that integrates AlphaFold-derived pLDDT confidence scores and Mahalanobis distance analysis to improve prediction accuracy, demonstrating its ability to predict pathogenic variants of four glycan-related proteins. These tools offer a novel avenue for uncovering previously unrecognized functions of glycogenes and their links to disease, and contribute to the clinical interpretation of genetic variation.
- 8 July 2025
- Published by Springer Nature in Journal of Human Genetics
Open AccessVarMeter: a prediction method for the impact of glycogene variants
The clinical relevance of glycans, which play a wide array of physiological roles, is underscored by the emergence of congenital disorders of glycosylation, a group of rare inherited diseases caused by defects in glycan-related genes (glycogenes). Biochemical studies of recombinant proteins and phenotypic analyses in knockout mice are revealing critical insights into the roles of various glycosyltransferases, glycosidases, and glycan-binding proteins. However, the biological functions of numerous glycogenes and their role in disease remain incompletely understood, partly due to human-specific functions that are not recapitulated in model organisms, and partly due to the structural diversity and complexity of glycan modifications, which are difficult to fully assess by conventional methods. A promising complementary strategy is the systematic assessment of human genetic variants, particularly missense mutations, to infer functional consequences. Recent developments in protein structure prediction, exemplified by AlphaFold, are facilitating the development of structure-based approaches to variant interpretation. In this review, we discuss current methodologies for predicting the impact of missense variants using structural information, and introduce VarMeter, a computational framework incorporating 3D structural parameters that has been successfully applied to the prediction of pathogenic variants in the ClinVar database. We also describe VarMeter2, an updated version that integrates AlphaFold-derived pLDDT confidence scores and Mahalanobis distance analysis to improve prediction accuracy, demonstrating its ability to predict pathogenic variants of four glycan-related proteins. These tools offer a novel avenue for uncovering previously unrecognized functions of glycogenes and their links to disease, and contribute to the clinical interpretation of genetic variation.
- Open Access
Comparative Conformational Analysis of Acyclic Sugar Alcohols Ribitol, Xylitol and d-Arabitol by Solution NMR and Molecular Dynamics Simulations
Ribitol (C5H12O5) is an acyclic sugar alcohol that was recently identified in O-mannose glycan on mammalian -dystroglycan. The conformation and dynamics of acyclic sugar alcohols such as ribitol are dependent on the stereochemistry of the hydroxyl groups; however, the dynamics are not fully understood. To gain insights into the conformation and dynamics of sugar alcohols, we carried out comparative analyses of ribitol, d-arabitol and xylitol by a crystal structure database search, solution NMR analysis and molecular dynamics (MD) simulations. The crystal structures of the sugar alcohols showed a limited number of conformations, suggesting that only certain stable conformations are prevalent among all possible conformations. The three-bond scholar coupling constants and exchange rates of hydroxyl protons were measured to obtain information on the backbone torsion angle and possible hydrogen bonding of each hydroxyl group. The 100 ns MD simulations indicate that the ribitol backbone has frequent conformational transitions with torsion angles between 180 and ±60, while d-arabitol and xylitol showed fewer conformational transitions. Taking our experimental and computational data together, it can be concluded that ribitol is more flexible than d-arabitol or xylitol, and the flexibility is at least in part defined by the configuration of the OH groups, which may form intramolecular hydrogen bonds.Open AccessComparative Conformational Analysis of Acyclic Sugar Alcohols Ribitol, Xylitol and d-Arabitol by Solution NMR and Molecular Dynamics Simulations
Ribitol (C5H12O5) is an acyclic sugar alcohol that was recently identified in O-mannose glycan on mammalian -dystroglycan. The conformation and dynamics of acyclic sugar alcohols such as ribitol are dependent on the stereochemistry of the hydroxyl groups; however, the dynamics are not fully understood. To gain insights into the conformation and dynamics of sugar alcohols, we carried out comparative analyses of ribitol, d-arabitol and xylitol by a crystal structure database search, solution NMR analysis and molecular dynamics (MD) simulations. The crystal structures of the sugar alcohols showed a limited number of conformations, suggesting that only certain stable conformations are prevalent among all possible conformations. The three-bond scholar coupling constants and exchange rates of hydroxyl protons were measured to obtain information on the backbone torsion angle and possible hydrogen bonding of each hydroxyl group. The 100 ns MD simulations indicate that the ribitol backbone has frequent conformational transitions with torsion angles between 180 and ±60, while d-arabitol and xylitol showed fewer conformational transitions. Taking our experimental and computational data together, it can be concluded that ribitol is more flexible than d-arabitol or xylitol, and the flexibility is at least in part defined by the configuration of the OH groups, which may form intramolecular hydrogen bonds.